Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3621-3630 Newer>

Chemistry World April 13, 2007 Victoria Gill	FDA Votes Against Vioxx Replacement The FDA's advisory committee has recommended that the agency does not approve Merck's latest arthritis drug Arcoxia, a drug in the same class as the company's withdrawn and now infamous Vioxx.
The Motley Fool April 13, 2007 Brian Lawler	MedImmune Wants a Mate The biopharma announces the hiring of investment bankers to look for a possible acquirer. Investors, take note.
Pharmaceutical Executive April 1, 2007 Joanna Breitstein	A Balancing Act Rather than remaking herself to fit the executive suite, Meryl Zausner has remade the executive suite -- and the pharma industry -- into a place that is more friendly toward women.
Pharmaceutical Executive April 1, 2007 Walter Armstrong	Make It New To fix pharma's business model, nothing less than big, bold, and risky fits the bill. Two radical new visions focus on getting back to the roots of innovation -- and letting a thousand flowers bloom.
Pharmaceutical Executive April 1, 2007 Papworth et al.	Get a Grip on the Supply Chain For the pharma industry, Sarbanes-Oxley revenue-recognition compliance is reducing perfectly competent execs to complete blubber. Here's help in figuring out when a sale is really a sale.
Pharmaceutical Executive April 1, 2007 McCook & Daniels	Making the Switch More companies are using Rx-to-OTC switches to extend a brand's life cycle. Prilosec did it. Here, experts dish on how you can do it too.
Pharmaceutical Executive April 1, 2007 Jill Wechsler	Washington Report: Medicaid Sets the Pace for Pharma Pricing Forget Medicare price negotiations. Pending changes in Medicaid drug-pricing formulas will put even more pressure on pharmaceutical prices.
Pharmaceutical Executive April 1, 2007 Patrick Clinton	From the Editor: Taking It Outside FDA Commissioner Andy von Eschenbach said something pretty reasonable, and in return received a blistering, menacing letter from Senator Charles Grassley -- a letter that showed yet again that Grassley just doesn't understand what he's destroying in his campaign against FDA.
Pharmaceutical Executive April 1, 2007 Joleen Schultz	Marketing to Professionals: Everyone's a Comedian An ad campaign doesn't have to be "ha-ha" funny to sell a drug, but it doesn't hurt.
Pharmaceutical Executive April 1, 2007 Kristin Rand	Back Page: Where are the Women? Despite efforts to increase diversity, the stark reality is that today's leading pharmaceutical companies are still run by men.
<Older 3621-3630 Newer> Return to current articles.